Biometrics Built Better

Rapid study rescue and regulatory-ready delivery for a critical Phase III submission

When a pivotal Phase III study encountered major data and quality issues close to submission, Veramed’s Flex Solutions provided a rapid rescue model.

Share this article

When a pivotal Phase III study encountered major data and quality issues close to submission, Veramed’s Flex Solutions provided a rapid rescue model. Within 12 weeks, key reporting deliverables were rebuilt, restoring confidence in the analysis package, and supporting a successful path to FDA supplemental Biologics License Application (sBLA) submission. 

The challenge

The sponsor was preparing a pivotal Phase III study for first-line treatment approval and FDA sBLA submission when the initial dry run revealed significant data and quality issues. With the next delivery only 12 weeks away, the sponsor needed a solution that could take over full reporting responsibilities while the original CRO continued in parallel to reduce risk. 

The solution

As a trusted biometrics partner, we applied a proven transition approach designed for high-pressure rescue situations. Our focus was to stabilize delivery quickly, protect quality, and give the sponsor a clear route to submission. 

  • Rapid assessment: Reviewed workload, risks, resources, and technical requirements within 48 hours before committing. 
  • Quality-first transition: Took ownership only once we were confident the timeline could be met without compromising standards. 
  • Specialist task force: Formed an expert biostatistics and programming team, strategically divided tasks to enable parallel execution, establish milestone checkpoints, accelerate delivery, and support timely decision-making. 
  • Structured delivery plan: Reassessed the SAP and ADaM specifications, then redeveloped and validated a complete set of ADaMs and TFLs. 
  • Transparent milestones: Managed rolling deliveries across four batches: one safety batch, two efficacy batches, and one combined batch. 
  • Ongoing sponsor alignment: Maintained clear communication around progress, risks, and submission-critical deadlines.

“When we assign mission-critical work to Veramed, we have peace of mind. That confidence comes from the trust we’ve built through years of working together.”  

Client Partnership Lead

The outcome

We successfully reworked the complete set of Clinical Study Reports (CSR) within three months. We revisited the entire process, revising the Statistical Analysis Plan (SAP) and ADaM specifications initially developed by the incumbent CRO, reworking 21 ADaMs and 300 TFLs across four batches to deliver the second dry run within the three-month timeframe. The sponsor selected our outputs for Dry Run #2 and appointed us to complete the final CSR and study submission. 

Our statisticians provided targeted biostatistical support for missing data, unexpected cases, and specialized methods, documenting decisions in the SAP and creating an eTMF tracking sheet for audit readiness. We then supported the study through database lock, CSR completion, and submission, delivering TFLs within three days of DBL and finalizing them within three weeks. 

  • Prepared 20 eCRT packages for submission readiness. 
  • Reworked legacy pharmacokinetic work in Excel. 
  • Ensured SDTM/ADaM CDISC and Define 2.0 compliance. 
  • Produced SDSP and BIMO packages to support the submission. 


A high-impact biometrics team specialized in tackling time-critical, complex scenarios. Explore our Flex Solutions Model.

Share this article

Stay Connected

Sign up to receive the latest insights, case studies, and Veramed news—straight to your inbox.

Related Posts